Aperza has raised ¥1.2B from Eight Roads Ventures Japan, SMBC Venture Capital, Mitsubishi UFJ Capital, JAFCO and GMO VenturePartners.
Every Inc. has raised ¥2.5B from ITOCHU-SHOKUHIN Co., Ltd.
Sansan just went Public to Mothers.
Key success factors and pitfalls for startups – insight from the 15 years experience of GMO VP
The application for the listing of Sansan, Inc. has officially been approved by Mothers (Market fo the high-growth and emerging stocks).
Balus CO., LTD. has raised ¥350M from three investors including GMO VenturePartners and MITSUI SUMITOMO INSURANCE Venture Capital Co.,Ltd.
SORABITO Inc. has raised ¥900M from SUMITOMO CORPORATION and ITOCHU CONSTRUCTION MACHINERY CO., LTD.
A new challenge to redefine the relationship between talents and companies
MOLCURE, the AI & Biotech scientists, change the game of drug discovery
Spready Inc. has received investment from GMO VenturePartners, UB Ventures and SMBC Venture Capital
MOLCURE Inc. has raised ¥250M from investors including GMO VenturePartners, The Dai-ichi Life Insurance Company and Nippon Chemiphar Company
Sansan, Inc. has raised 3 billion yen from Japan Post Capital Co.,Ltd., T. Rowe Price Japan Fund, SBI Investment Co., Ltd., and DCM Ventures.